Related Experiment Video
Updated: Aug 22, 2025

Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting
Published on: March 25, 2019
Nanotechnology-Based Nucleic Acid Vaccines for Treatment of Ovarian Cancer
Simav Gildiz1, Tamara Minko2,3
1Department of Pharmaceutics, Rutgers, the State University of New Jersey, Piscataway, NJ, USA.
Abstract:
Anticancer vaccines represent a promising approach for effective treatment of cancer and along with recent advantages of nucleic acid-based vaccines for other diseases form a prospective and potentially efficacious direction of the research, development and clinical applications. Despite the ongoing several clinical trials of mRNA vaccines for the treatment of various types of cancer, to-date no cancer vaccines were approved by the US Food and Drug Administration. The present review analyzes and summarizes major approaches for treating of different forms of ovarian cancer including mRNA-based vaccines as well as nanotechnology-based approaches for their delivery.
Insights
Messenger RNA (mRNA) vaccines show promise for treating cancer, but none are FDA-approved yet. This review covers mRNA and nanotechnology approaches for ovarian cancer treatment.
Area of Science:
- Oncology
- Vaccinology
- Biotechnology
Background:
- Anticancer vaccines are a promising therapeutic strategy.
- Nucleic acid-based vaccines have advanced significantly for other diseases.
- Current research explores mRNA vaccines for various cancers.
Purpose of the Study:
- To review major treatment approaches for ovarian cancer.
- To analyze the role of mRNA-based vaccines in ovarian cancer therapy.
- To summarize nanotechnology-based delivery systems for cancer vaccines.
Main Methods:
- Literature review of current research and clinical trials.
- Analysis of mRNA vaccine technology for cancer treatment.
- Evaluation of nanotechnology applications in vaccine delivery.
Main Results:
- While promising, no mRNA cancer vaccines are currently FDA-approved.
- Several clinical trials are investigating mRNA vaccines for different cancers.
- Nanotechnology offers potential for improved vaccine delivery.
Conclusions:
- mRNA vaccines represent a prospective direction for cancer research and development.
- Nanotechnology-based approaches are crucial for effective mRNA vaccine delivery.
- Further research is needed to advance ovarian cancer vaccine therapies.
More Related Videos
14:20Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
09:02Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
Published on: September 27, 2024
Related Concept Videos
Nucleic acids
DNA and RNA
The two main types of nucleic acids are deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). DNA is the genetic material in all living organisms, ranging from single-celled bacteria to multicellular mammals. It is in the nucleus of eukaryotes and in the organelles, chloroplasts, and mitochondria. In prokaryotes,...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Microorganisms in Medicine and Therapeutics